|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CARACO PHARMACEUTICAL LABORATORIES LTD, 10QSB, EX-4, 2000-11-13 |
Next: KEMET CORP, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 817,784
<SECURITIES> 0
<RECEIVABLES> 678,207
<ALLOWANCES> 145,000
<INVENTORY> 1,475,345
<CURRENT-ASSETS> 2,923,371
<PP&E> 11,397,786
<DEPRECIATION> 4,292,050
<TOTAL-ASSETS> 10,029,107
<CURRENT-LIABILITIES> 11,636,474
<BONDS> 0
0
1,000,000
<COMMON> 0
<OTHER-SE> (48,666,993)
<TOTAL-LIABILITY-AND-EQUITY> 10,029,107
<SALES> 1,924,709
<TOTAL-REVENUES> 1,924,709
<CGS> 1,915,793
<TOTAL-COSTS> 1,915,793
<OTHER-EXPENSES> (4,273,000)
<LOSS-PROVISION> 145,000
<INTEREST-EXPENSE> (1,172,865)
<INCOME-PRETAX> (5,445,864)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5,445,864)
<EPS-BASIC> (0.28)
<EPS-DILUTED> (0.28)
</TABLE>
|
|